Ignite Creation Date:
2025-12-24 @ 11:31 PM
Ignite Modification Date:
2025-12-25 @ 9:19 PM
Study NCT ID:
NCT04530656
Status:
COMPLETED
Last Update Posted:
2022-06-01
First Post:
2020-08-27
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Phase I Trial of a Recombinant SARS-CoV-2 Vaccine (Sf9 Cell)
Sponsor:
Jiangsu Province Centers for Disease Control and Prevention
Organization:
Organization Data
Organization:
Class:
NETWORK
Study ID:
JSVCT098
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
NETWORK
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | OTHER | View |